Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) reports the results of the company's Annual General Meeting (AGM) held on May 6, 2010. The filing confirms that all resolutions presented to shareholders were passed.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance metrics.
Material Changes Versus Prior Period
Comparative data regarding the 2009 AGM indicates the following changes in shareholder engagement:
- Share Capital: Issued share capital (excluding Treasury Shares) increased from 5,188,385,638 in 2009 to 5,192,489,588 in 2010.
- Voting Participation: The percentage of issued share capital represented by votes cast and withheld decreased from 73.50% in 2009 to 70.24% in 2010.
- Shareholder Population: The total shareholder population declined from 170,054 in 2009 to 164,450 in 2010.
- Proxy Lodging: The percentage of shareholders lodging proxies increased slightly from 6.22% to 6.78%.
Guidance, Outlook, and Governance Results
The AGM results demonstrate strong shareholder support for management and board proposals. Key outcomes include:
- Financial Statements: Adopted with 98.82% of votes cast in favor.
- Remuneration Report: Approved with 97.79% of votes cast in favor.
- Board Elections: All six directors standing for re-election (Dr. Stephanie Burns, Julian Heslop, Sir Deryck Maughan, Dr. Daniel Podolsky, and Sir Robert Wilson) received over 99% support.
- Auditor Appointment: The re-appointment of auditors received 96.93% support, while auditor remuneration received 98.45% support.
- Share Authority: Shareholders authorized the allotment of shares (96.76% for) and the purchase of own shares (98.56% for).
- Political Expenditure: Authority to make donations to political organizations was approved with 97.36% support.
- Articles of Association: The adoption of new Articles of Association passed with 99.44% support.
The filing contains no specific guidance, outlook, or discussion of risks and contingencies beyond the standard AGM resolutions.
Investor Verification Checklist
- Verify the full text of the new Articles of Association adopted at the AGM.
- Review the specific terms of the authority granted for share allotment and buybacks.
- Confirm the details of the political expenditure authorization limits.
- Check the company website (www.gsk.com) for the detailed financial statements referenced in Resolution 1.